Levothyroxine Sodium Tablet
Product Images NDC 68071-3692

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68071-3692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucarepharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)
Chemical structure diagram of Levothyroxine Sodium showing its molecular composition, including iodine atoms, hydroxyl group, and sodium salt components. The diagram represents the active ingredient Levothyroxine Sodium in the product.*
FDA Label Image

Pdp (68071 3692 9)

Pdp (68071 3692 9)
Packaging label for Levothyroxine Sodium 125 mcg tablets by NuCare Pharmaceuticals, Inc. The label shows a quantity of 90 tablets, made by Lupin Limited in India. It includes warnings to keep out of reach of children and to store at controlled temperatures 68-77°F. The label also features NDC numbers, lot and expiration date placeholders, and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.